Perspective Therapeutics SG&A Expense (Quarterly) Insights

Perspective Therapeutics Inc (CATX)

1.695 +0.06 (+3.35%) USD | NYAM | Apr 30, 16:00

1.695 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1998. Upgrade now.

Date	Value
December 31, 2023	1.694M
September 30, 2023	5.551M
June 30, 2023	5.984M
March 31, 2023	7.835M
September 30, 2022	3.914M
June 30, 2022	2.236M
March 31, 2022	2.268M
December 31, 2021	2.32M
September 30, 2021	2.601M
June 30, 2021	1.971M
March 31, 2021	1.764M
December 31, 2020	1.748M
September 30, 2020	1.648M
June 30, 2020	1.938M
March 31, 2020	1.96M
December 31, 2019	1.737M
September 30, 2019	1.912M
June 30, 2019	1.682M
March 31, 2019	1.744M
December 31, 2018	1.803M
September 30, 2018	1.622M
June 30, 2018	2.235M
March 31, 2018	1.475M
December 31, 2017	1.659M
September 30, 2017	1.455M

Date	Value
June 30, 2017	2.048M
March 31, 2017	1.355M
December 31, 2016	1.376M
September 30, 2016	1.451M
June 30, 2016	1.519M
March 31, 2016	1.211M
December 31, 2015	1.379M
September 30, 2015	1.03M
June 30, 2015	1.153M
March 31, 2015	0.9648M
December 31, 2014	0.8417M
September 30, 2014	0.9297M
June 30, 2014	1.005M
March 31, 2014	0.8474M
December 31, 2013	0.8404M
September 30, 2013	1.010M
June 30, 2013	0.9507M
March 31, 2013	0.8736M
December 31, 2012	0.8566M
September 30, 2012	0.9609M
June 30, 2012	0.967M
March 31, 2012	0.8348M
December 31, 2011	0.8013M
September 30, 2011	0.9673M
June 30, 2011	0.9259M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.648M

Minimum

Sep 2020

7.835M

Maximum

Mar 2023

2.820M

Average

1.966M

Median

SG&A Expense (Quarterly) Benchmarks